AGIO up +1.82% percent Today $AGIO High is at 85.45 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 1:00 PM

AGIO up +1.82% percent Today $AGIO High is at 85.45 and the Low 81.48 with current volume of 288,621.

Recent News posted below.

Agios Pharmaceuticals Inc AGIO other info.
http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/

AGIO Agios Pharmaceuticals Inc Recent Headline News

Nasdaq stocks posting largest percentage increases
AP - Mon Nov 10, 5:07PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
OREX: 5.14 (+0.01), PCMI: 8.60 (-0.20), ACHN: 13.10 (+0.25), TGTX: 12.80 (+0.25), AGIO: 83.94 (+2.16), LIOX: 5.33 (-0.21), PLNR: 6.78 (-0.90)

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST

XBI: 173.84 (+1.69), SLXP: 96.86 (+2.99), ICPT: 174.19 (-2.16), IBB: 297.01 (+1.81), AGIO: 83.94 (+2.16)

Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST

AGIO: 83.94 (+2.16)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST

BEBE: 2.39 (+0.01), ANET: 76.64 (-0.15), TKMR: 16.17 (-0.31), ORBC: 6.37 (+0.30), MDRX: 11.09 (-0.19), RMTI: 11.15 (+0.25), CTIC: 2.19 (+0.05), SHLD: 37.86 (-0.86), UBNT: 28.56 (-0.64), RIG: 28.91 (-0.37), KGC: 2.42 (+0.08), APT: 3.02 (-0.09), ANF: 28.98 (+0.29), MITK: 3.37 (+0.22), ZNGA: 2.65 (+0.17), CNET: 2.14 (-0.01), KING: 13.80 (+0.06), NETE: 1.53 (+0.04), SLXP: 96.86 (+2.99), RPRX: 9.10 (-0.12), NADL: 5.00 (-0.12), PGNX: 6.51 (+0.54), AVNR: 13.35 (+0.13), FSLR: 51.39 (-0.57), DVA: 74.97 (+0.25), NDLS: 24.10 (-0.47), ICPT: 174.19 (-2.16), AGIO: 83.94 (+2.16), PLNR: 6.78 (-0.90)

Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST

AGIO: 83.94 (+2.16)

Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 83.94 (+2.16)

Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 83.94 (+2.16)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:30PM CST

BAM: 49.47 (-0.84), ERF: 15.17 (+0.76), LXP: 10.98 (-0.05), PGEM: 13.08 (+0.06), CCOI: 34.28 (+1.01), TTI: 8.62 (+0.04), SJI: 58.22 (+0.24), NXST: 44.92 (+0.40), VSAT: 62.93 (-0.08), MT: 12.12 (-0.13), LXU: 30.90 (-0.59), HUM: 134.50 (+2.04), PGNX: 6.51 (+0.54), MHR: 4.54 (+0.01), CTB: 32.66 (-0.07), IDRA: 2.60 (+0.07), ISIS: 51.06 (+3.83), BPL: 77.15 (-1.47), SSP: 18.41 (-0.15), AGIO: 83.94 (+2.16), EBIX: 16.52 (+0.92)

Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 93.62 (+0.39), RNA: 12.03 (+0.03), AGIO: 83.94 (+2.16), CELG: 107.99 (-0.02)

Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
GlobeNewswire - Thu Nov 06, 8:46AM CST
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation
AGIO: 83.94 (+2.16)

Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Nov 03, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, IMPV, NSC, HAL and AGIO.
NSC: 116.17 (-0.43), LNKD: 227.70 (-1.55), HAL: 53.01 (-0.62), AGIO: 83.94 (+2.16), IMPV: 43.26 (+0.17)

Super Important Biotech and Drug Stock Events for November
at The Street - Mon Nov 03, 7:24AM CST
A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for healthcare investors.
GILD: 108.55 (+1.53), CLVS: 61.25 (+1.11), ARWR: 6.33 (+0.12), ACHN: 13.09 (+0.24), MRK: 59.57 (+0.76), RTRX: 10.90 (+0.16), RGLS: 20.49 (-0.42), EPZM: 24.75 (+0.88), AGIO: 83.94 (+2.16), RMTI: 11.15 (+0.25), ARNA: 4.50 (+0.10), KERX: 16.17 (-0.26)

Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Oct 29, 5:59AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday October 2 8. Bullish Calls: Isis Pharmaceuticals (NASDAQ: ISIS ): "Isis got slammed, and (the selloff) was overdone. It has the best pipeline...
GS: 192.15 (+0.35), RICE: 28.48 (+0.52), ISIS: 51.09 (+3.86), CYBR: 34.33 (-0.55), GNC: 43.20 (+0.15), HAL: 53.01 (-0.62), AGIO: 83.94 (+2.16), FTNT: 27.14 (+0.02)

'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals
at The Street - Wed Oct 29, 5:00AM CDT
Cramer says Halliburton is a buy, buy, buy and GNC needs to merge with Vitamin Shoppe.
VSI: 47.11 (-0.27), RICE: 28.48 (+0.52), GS: 192.15 (+0.35), FEYE: 32.36 (-0.03), ISIS: 51.09 (+3.86), CYBR: 34.33 (-0.55), GNC: 43.20 (+0.15), HAL: 53.01 (-0.62), EOG: 98.10 (-0.40), AGIO: 83.94 (+2.16), FTNT: 27.14 (+0.02)

Jim Cramer's 'Mad Money' Recap: Winners in the Expectations Game
at The Street - Tue Oct 28, 7:26PM CDT
It's expectations, not the earnings, that determine the direction of a company's stock price, and several companies proved that today, Cramer says.
KSS: 56.26 (-0.31), FEYE: 32.36 (-0.03), CYBR: 34.33 (-0.55), FB: 74.30 (-0.70), GNC: 43.20 (+0.15), HAL: 53.01 (-0.62), AGCO: 45.13 (-0.11), BWLD: 161.50 (+2.27), MAS: 23.22 (+0.04), YHOO: 48.70 (-0.71), WHR: 175.50 (+1.71), VSI: 47.11 (-0.27), SAVE: 79.18 (+0.13), RICE: 28.48 (+0.52), GS: 192.15 (+0.35), PH: 127.68 (-0.75), ISIS: 51.09 (+3.86), CMI: 146.01 (-0.49), EOG: 98.10 (-0.40), AGIO: 83.94 (+2.16), TWTR: 39.14 (-0.45), FTNT: 27.14 (+0.02), BABA: 115.68 (-3.47)

Can Celgene Corporation Stock Motor to $150 Following Earnings?
Sean Williams, The Motley Fool - Motley Fool - Tue Oct 28, 7:03AM CDT
Just as the proverbial American worker stamps their time card on a daily basis and does their job, biotech giant Celgene continues to deliver for shareholders without fail. Last Thursday, Celgene dazzled investors yet again by reporting better...
OMED: 21.90 (+1.61), AGIO: 83.94 (+2.16), CELG: 107.99 (-0.02)

Forget MannKind Corporation: 3 Better Stocks
Motley Fool Staff - Motley Fool - Mon Oct 27, 8:13AM CDT
Source: MannKind. A doubling of Americans diagnosed with diabetes over the coming decade may support demand for MannKind 's inhalable insulin Afrezza, but that doesn't necessarily mean that MannKind is biotech's best idea. We asked three of...
DXCM: 52.83 (-0.67), NVAX: 5.36 (+0.15), AGIO: 83.94 (+2.16), SNY: 46.66 (+0.47), MNKD: 6.07 (+0.19), CELG: 107.99 (-0.02)

Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014
GlobeNewswire - Mon Oct 27, 7:41AM CDT
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that it will host a conference call and live webcast on Friday, November 7, 2014, at 8:00 a.m. EST to report its third quarter 2014 financial results and discuss recent business activities.
AGIO: 83.94 (+2.16)

Fab Four - Got To Get You Into My Life
Leonard Yaffe - at Seeking Alpha - Fri Oct 24, 12:24PM CDT

GILD: 108.55 (+1.53), MRK: 59.57 (+0.76), AGIO: 83.94 (+2.16), REGN: 397.30 (+11.33)

Agios Pharmaceuticals Inc. (AGIO) Stock Research Links

AGIO Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bernard Lancaster Steps Up as Mammoth's New President

A New Era Under Bernard Lancaster at Mammoth Change is in the air for Mammoth Energy Services, as Bernard “Bernie” Lancaster takes the helm as President. His promotion on November 9, 2026, might not send shockwaves through Wall Street right away, but anyone holding an interest in NASDAQ:TUSK should take note. Lancaster's appointment is the kind of decision that...

Nuix Names Lori Cornmesser to Head Global Partnerships

Nuix Shakes Things Up with New Leadership Nuix, a notable player in the investigative analytics and intelligence software space, just leveled up its game by bringing in Lori Cornmesser as the Global Vice President, Partner Ecosystems. This ain't your average hire. Cornmesser's been around the block—over 25 years, in fact—building and leading partner ecosystems...

Global Case Studies in Poverty Reduction Spotlighted

A Fresh Spotlight on Poverty Reduction Efforts Amid the clamor of social and economic challenges, 126 stellar case studies of poverty reduction just took center stage at a seminar in Beijing. These admired initiatives emerged from the seventh global solicitation, chosen from a pile of 890 entries submitted by do-gooders and organizations spanning 31 countries. If you've...

MGS Extends Engagement for BECI Power Line Project

The power game isn't always about flipping switches, my friends. With Midcontinent Grid Solutions (MGS), we're seeing another round of crowd-pleasing playacting as they pump the brakes on the BECI Project. New timeline, new promises—same old story. Investors, environmentalists, and citizens alike are watching this one unfold with a glass of iced tea and crossed fingers....

FF EAI Robotics Aims for Top Spot in K-12 Tech

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Maritime Launch's Bold Q3 Surge Amid Space Race

Rockets, Revenue, and a Bold New Path You ever hear about a spaceport tucked away in the toes of Nova Scotia, making waves with its third-quarter earnings? Well, that's exactly what's cooking over at Maritime Launch Services. These folks have managed to turn a zero into hero in a flash, reporting $5.6 million in revenue and a snug $3.5 million in net income for Q3 2026....

Etavopivat Aims to Tackle Sickle Cell Crisis Head-On

Diving headfirst into the world of sickle cell disease, Novo Nordisk has just thrown its hat in the ring with etavopivat. Now, anyone who's been following the biotech dance knows this ain't no small feat. This investigational therapy is poised to shake things up, offering a new lifeline for those wrestling with this debilitating condition. And leaping from the Phase 3...

MJ Cultivate: A New Stage for Cannabis Pioneers

Spotlight on Cannabis Innovators Look, anyone with skin in the game knows the cannabis industry is more than just shimmering stores and glossy products. It's got deep roots, and those roots grow from the hands of folks tirelessly working the soil, engineering extracts, and perfecting every last breath of a bud. That's who Jage Media's latest brainchild, MJ Cultivate,...

YYForce Expands in UAE with Key Hospitality Wins

Unveiling YYForce's Middle East Strategy Smack in the middle of an aggressive Middle Eastern expansion, YYForce (NASDAQ: YFOR) is making waves with some new headline-grabbing contracts in the UAE. This ain't just a side hustle—it's big time. They're planting their flag across the luxury hospitality sector like they're going for a moon landing. The recent announcement...

Miami Gala Raises $200K for Teen Emotional Health

A Night of Giving and Growth in Miami Ever felt like a single evening could change the world? Well, that's exactly what happened on November 7th at the Britto Palace in Miami. The Ismael Cala Foundation pulled off a remarkable feat, raising over $200,000 to boost emotional intelligence among teens through its annual gala, Legacy of Light: A Night of Joyful Giving. The...